Pfizer Inc.

Symbol: PFE     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
3.39%
Current Price
$42.54
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-11 04:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
13,118,000,000
13,118,000,000
2,433,000,000
10,685,000,000
6,225,000,000
4,460,000,000
3,884,000,000
-
-
n.a.
-
-
-
-
-
-
-
 
1,703,000,000

Financials 2018

Update: 2019-06-11 04:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
13,977,000,000
13,977,000,000
3,075,000,000
10,902,000,000
7,717,000,000
3,185,000,000
-393,000,000
49,926,000,000
159,422,000,000
95,664,000,000
63,407,000,000
1,225,000,000
8,831,000,000
18,833,000,000
41,740,000,000
-2,433,000,000
4,738,000,000
 
2,457,000,000

Q 3

2018-09-30
13,298,000,000
13,298,000,000
2,694,000,000
10,604,000,000
6,755,000,000
3,849,000,000
4,114,000,000
41,583,000,000
167,838,000,000
96,174,000,000
71,319,000,000
3,658,000,000
14,770,000,000
17,239,000,000
48,422,000,000
948,000,000
5,259,000,000
 
2,008,000,000

Q 2

2018-06-30
13,466,000,000
13,466,000,000
2,916,000,000
10,550,000,000
6,530,000,000
4,020,000,000
3,872,000,000
37,303,000,000
164,980,000,000
94,856,000,000
69,778,000,000
2,811,000,000
11,583,000,000
13,431,000,000
40,518,000,000
465,000,000
3,847,000,000
 
1,797,000,000

Q 1

2018-03-31
12,906,000,000
12,906,000,000
2,563,000,000
10,343,000,000
6,351,000,000
3,992,000,000
3,561,000,000
34,835,000,000
164,612,000,000
94,071,000,000
70,184,000,000
2,416,000,000
9,011,000,000
11,421,000,000
40,842,000,000
930,000,000
1,983,000,000
 
1,743,000,000

Financials 2017

Update: 2019-06-11 04:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
13,703,000,000
13,703,000,000
3,268,000,000
10,435,000,000
8,012,000,000
2,423,000,000
12,274,000,000
41,141,000,000
171,797,000,000
100,141,000,000
71,308,000,000
1,342,000,000
9,954,000,000
19,992,000,000
43,492,000,000
-1,431,000,000
6,757,000,000
 
2,290,000,000